Are you Dr. Ko?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 4 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
330 Brookline Ave
Beth Israel Deaconess Med
Boston, MA 02215
Summary
- Dr. Yoo-Joung Ko, MD is an oncologist in Boston, Massachusetts.
Education & Training
Beth Israel Deaconess Medical CenterFellowship, Hematology and Medical Oncology, 1996 - 1999
Clinical Trials
- Single Agent Abraxane as Second Line Therapy in Bladder Cancer Start of enrollment: 2008 Mar 01
- SGI-110 in the Treatment of Advanced Hepatocellular Carcinoma (HCC) Start of enrollment: 2012 Dec 01
- Study of TRIFLURIDINE/TIPIRACIL in Previously Treated Cholangiocarcinoma Start of enrollment: 2019 Dec 11
Publications & Presentations
PubMed
- 427 citationsBiology of prostate-specific antigen.Steven P. Balk, Yoo Joung Ko, Glenn J. Bubley
Journal of Clinical Oncology. 2003-01-15 - 448 citationsSelection for Androgen Receptor Mutations in Prostate Cancers Treated with Androgen AntagonistMary-Ellen Taplin, Glenn J. Bubley, Yoo-Joung Ko, Eric J. Small, Melissa P. Upton
Cancer Research. 1999-06-01 - 47 citationsSafety, pharmacokinetics, and biological pharmacodynamics of the immunocytokine EMD 273066 (huKS-IL2): results of a phase I trial in patients with prostate cancer.Yoo-Joung Ko, Glenn J. Bubley, Robert Weber, Charles H. Redfern, Daniel P. Gold
Journal of Immunotherapy. 2004-05-01
Professional Memberships
- Member
